Furthermore, considering that approximately 30% of tumor biopsy samples may be insufficient to perform ALK characterization, promising data are available on the role of circulating tumor cells as a surrogate to tissue for the detection of ALK alterations [54]. Here, ALK is linked to neoplasm.